Monday's session: top gainers and losers
By Mill Chart
Last update: Jan 23, 2023
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Gainers
| Ticker | Change | Comment |
|---|---|---|
| JAGX | 7.0K% | JAGUAR HEALTH INC's (NASDAQ:JAGX) shares rose 7.0K% to $5.37. The stock is trading 41.59% lower than 3 months ago. |
| SIEN | 752.0% | SIENTRA INC's (NASDAQ:SIEN) shares rose 752.0% to $1.79 during Monday's session. The stock is trading 29.03% lower than 3 months ago. |
| OCSL | 201.0% | OAKTREE SPECIALTY LENDING CO (NASDAQ:OCSL) rose 201.0% to $21.14 during Monday's after hours session. |
| HLBZ | 92.39% | HELBIZ INC's (NASDAQ:HLBZ) stock price increased by 92.39% to $0.39. Earlier today the company had a press release: Helbiz Hires ShareIntel for Due Diligence, Advancing in Battle Against Illegal Short Selling. |
| GNS | 91.98% | GENIUS GROUP LTD's (NYSEARCA:GNS) stock price is advancing with 91.98% to a price of $6.22. Yesterday the company had a press release: Genius Group 2023 Financial Guidance: $48m - $52m Revenue, Positive EBITDA. |
| VERB | 81.07% | VERB TECHNOLOGY CO INC's (NASDAQ:VERB) stock price is advancing with 81.07% to a price of $0.41. In the last month the stock gained 101.0%. |
| FFIE | 50.66% | FARADAY FUTURE INTELLIGENT E's (NASDAQ:FFIE) shares rose 50.66% to $0.92 during Monday's session. In the last month the stock gained 71.05%. |
| PLRX | 36.48% | PLIANT THERAPEUTICS INC's (NASDAQ:PLRX) shares rose 36.48% to $30.72 during Monday's session. A press release (Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis) was released yesterday. |
| CEI | 33.93% | CAMBER ENERGY INC (NYSEARCA:CEI) rose 33.93% to $2.41 during Monday's after hours session. In the last month the stock lost 57.14%. |
| FFIEW | 33.33% | FARADAY FUTURE -CW27 (NASDAQ:FFIEW) rose 33.33% to $0.12 during Monday's after hours session. Shareholders saw the stock price going 50.68% higher in the past month. |
For the full top gainers list go to our top gainers screener.
Top losers
| Ticker | Change | Comment |
|---|---|---|
| NOGNW | -33.33% | SOFTWARE ACQ GROUP III -CW27's (NASDAQ:NOGNW) stock price is declining with 33.33% to a price of $0.04. Shareholders saw the stock price going 168.0% higher in the past month. |
| CPRX | -31.35% | CATALYST PHARMACEUTICALS INC's (NASDAQ:CPRX) shares fell 31.35% to $14.28 during Monday's session. Earlier today the company had a press release: Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra. |
| AMV | -24.56% | ATLIS MOTOR VEHICLES I- CL A's (NASDAQ:AMV) shares fell 24.56% to $3.42 during Monday's session. Earlier today the company had a press release: Atlis Motor Vehicles Battery Cell Output Increases 15x as Production Ramps to Meet Customer Demand. |
| PLBY | -20.73% | PLBY GROUP INC's (NASDAQ:PLBY) shares fell 20.73% to $2.92 during Monday's session. Shareholders saw the stock price going 41.05% lower is the past 6 months. |
| OTRK | -20.7% | ONTRAK INC's (NASDAQ:OTRK) shares fell 20.7% to $0.84. The stock is trading 179.0% higher than a month ago. |
| ZINGW | -20.0% | FTAC ZEUS ACQ C CL A -CW27's (NASDAQ:ZINGW) shares fell 20.0% to $0.04. The stock is trading 257.0% higher than a month ago. |
| EAR | -16.76% | EARGO INC's (NASDAQ:EAR) stock price is declining with 16.76% to a price of $12.12. In the last month the stock gained 23.39%. |
| VOC | -16.35% | VOC ENERGY TRUST's (NYSE:VOC) stock price is declining with 16.35% to a price of $10.95. The stock is trading 45.61% higher than a month ago. |
| NEON | -14.69% | NEONODE INC's (NASDAQ:NEON) stock price decreased by 14.69% to $10.86. The stock is trading 138.0% higher than a month ago. |
| PLX | -13.17% | PROTALIX BIOTHERAPEUTICS INC's (NYSEARCA:PLX) shares fell 13.17% to $1.45 during Monday's session. In the last month the stock gained 28.46%. |
For the full top loser list go to our top losers screener.
CATALYST PHARMACEUTICALS INC
NASDAQ:CPRX (4/19/2024, 4:46:52 PM)
After market: 15.189 +0.06 (+0.39%)15.13
-0.21 (-1.37%)
CPRX News
11 days ago - Market News VideoInvestors Grab CPRX Even Lower Than Its Secondary Stock Offering17 days ago - Market News VideoFirst Week of May 17th Options Trading For Catalyst Pharmaceuticals (CPRX)
22 days ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness DayCORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (
23 days ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy SymposiumCORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (
23 days ago - InvestorPlace3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch ListDon’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year.
a month ago - InvestorPlace7 Biotech Stocks Ready to Ride the Sector’s ResurgenceWith investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
a month ago - Investor's Business DailyMadrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating BenchmarkOn Monday, Madrigal Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating jump to 83 from 69 a day ago.
a month ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)AGAMREE® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile ...
a month ago - InvestorPlace3 Sexy Small-Cap Stocks to Add Sizzle to Your PortfolioWhile small-cap stocks can be incredibly risky, they also offer the potential for dramatic gains you won’t find with the big dogs.
